TK vs. TRDA

Last updated Jul 17, 2026

TK (Teekay Corporation) and TRDA (Entrada Therapeutics, Inc.) are both stocks. TK operates in Oil & Gas Midstream (Energy), while TRDA operates in Biotechnology (Healthcare). Over the past 3 years, TK returned 46.47%/yr vs -25.46%/yr for TRDA. At a 0.10 correlation, their price movements are largely independent.

Performance

TK vs. TRDA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Teekay Corporation (TK) and Entrada Therapeutics, Inc. (TRDA). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, TK achieves a 30.97% return, which is significantly higher than TRDA's -33.17% return.

TK

• 1D: -0.55%
• 1M: -9.66%
• 6M: 22.05%
• YTD: 30.97%
• 1Y: 57.48%
• 3Y*: 46.47%
• 5Y*: 47.10%
• 10Y*: 11.94%

TRDA

• 1D: -3.38%
• 1M: 5.69%
• 6M: -36.51%
• YTD: -33.17%
• 1Y: 7.68%
• 3Y*: -25.46%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

TK vs. TRDA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
TK Teekay Corporation	30.97%	48.20%	47.41%	57.49%	44.59%	-11.80%
TRDA Entrada Therapeutics, Inc.	-33.17%	-40.54%	14.58%	11.61%	-21.03%	-35.40%

Correlation

The correlation between TK and TRDA is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.12
Correlation (3Y) Calculated over the trailing 3-year period	0.10
Correlation (All Time) Calculated using the full available price history since Oct 29, 2021	0.10

Fundamentals

Market Cap TK : $951.91M TRDA : $266.70M
EPS TK : $0.81 TRDA : -$4.00
PS Ratio TK : 0.94 TRDA : 49.76
PB Ratio TK : 0.44 TRDA : 1.06
Total Revenue (TTM) TK : $1.00B TRDA : $5.74M
Gross Profit (TTM) TK : $239.59M TRDA : -$34.38M
EBITDA (TTM) TK : $388.35M TRDA : -$172.23M

Return for Risk

TK vs. TRDA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TK

TK Risk / Return Rank: 83
TK Sharpe Ratio Rank: 86
TK Sortino Ratio Rank: 83
TK Omega Ratio Rank: 79
TK Calmar Ratio Rank: 82
TK Martin Ratio Rank: 85

TRDA

TRDA Risk / Return Rank: 52
TRDA Sharpe Ratio Rank: 48
TRDA Sortino Ratio Rank: 53
TRDA Omega Ratio Rank: 60
TRDA Calmar Ratio Rank: 48
TRDA Martin Ratio Rank: 48

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TK vs. TRDA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Teekay Corporation (TK) and Entrada Therapeutics, Inc. (TRDA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	TK	TRDA	Difference
Sharpe ratio: Return per unit of total volatility	1.58	0.09	+1.49
Sortino ratio: Return per unit of downside risk	2.22	0.79	+1.44
Omega ratio: Gain probability vs. loss probability	1.26	1.14	+0.12
Calmar ratio: Return relative to maximum drawdown	2.42	0.12	+2.30
Martin ratio: Return relative to average drawdown	7.32	0.29	+7.03

TK vs. TRDA - Sharpe Ratio Comparison

The current TK Sharpe Ratio is 1.58, which is higher than the TRDA Sharpe Ratio of 0.09. The chart below compares the historical Sharpe Ratios of TK and TRDA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

TK vs. TRDA - Drawdown Comparison

The maximum TK drawdown since its inception was -97.03%, which is greater than TRDA's maximum drawdown of -85.66%. Use the drawdown chart below to compare losses from any high point for TK and TRDA.

Drawdown Indicators

	TK	TRDA	Difference
Max Drawdown Largest peak-to-trough decline	-97.03%	-85.66%	-11.37%
Max Drawdown (1Y) Largest decline over 1 year	-23.83%	-64.75%	+40.92%
Max Drawdown (3Y) Largest decline over 3 years	-32.17%	-76.75%	+44.58%
Max Drawdown (5Y) Largest decline over 5 years	-32.17%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-83.87%	—	—
Current Drawdown Current decline from peak	-64.68%	-80.37%	+15.69%
Average Drawdown Average peak-to-trough decline	-47.85%	-63.08%	+15.23%
Ulcer Index Depth and duration of drawdowns from previous peaks	7.88%	26.70%	-18.82%

Volatility

TK vs. TRDA - Volatility Comparison

The current volatility for Teekay Corporation (TK) is 14.06%, while Entrada Therapeutics, Inc. (TRDA) has a volatility of 17.90%. This indicates that TK experiences smaller price fluctuations and is considered to be less risky than TRDA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	TK	TRDA	Difference
Volatility (1M) Calculated over the trailing 1-month period	14.06%	17.90%	-3.84%
Volatility (6M) Calculated over the trailing 6-month period	28.50%	96.13%	-67.63%
Volatility (1Y) Calculated over the trailing 1-year period	36.64%	85.41%	-48.77%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	41.64%	89.56%	-47.92%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	55.54%	89.56%	-34.02%

Dividends

TK vs. TRDA - Dividend Comparison

TK's dividend yield for the trailing twelve months is around 9.14%, while TRDA has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
TK Teekay Corporation	9.14%	11.07%	46.90%	0.00%	0.00%	0.00%	0.00%	1.03%	6.59%	2.36%	2.74%	17.55%
TRDA Entrada Therapeutics, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

Frequently Asked Questions

Can I hold both TK and TRDA in my portfolio?

TK and TRDA have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, TK or TRDA?

TRDA has higher volatility (17.90%) compared to TK (14.06%). In terms of maximum drawdown, TK dropped -97.03% vs TRDA's -85.66%.

Which has better risk-adjusted returns?

TK currently has the higher Sharpe Ratio (1.58 vs 0.09), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.